BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28671633)

  • 1. L1210 Cells Overexpressing ABCB1 Drug Transporters Are Resistant to Inhibitors of the N- and O-glycosylation of Proteins.
    Pavlikova L; Seres M; Hano M; Bohacova V; Sevcikova I; Kyca T; Breier A; Sulova Z
    Molecules; 2017 Jul; 22(7):. PubMed ID: 28671633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tunicamycin depresses P-glycoprotein glycosylation without an effect on its membrane localization and drug efflux activity in L1210 cells.
    Sereš M; Cholujová D; Bubenčíkova T; Breier A; Sulová Z
    Int J Mol Sci; 2011; 12(11):7772-84. PubMed ID: 22174631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of GRP78/BiP in P-Glycoprotein-Positive L1210 Cells is Responsible for Altered Response of Cells to Tunicamycin as a Stressor of the Endoplasmic Reticulum.
    Šereš M; Pavlíková L; Boháčová V; Kyca T; Borovská I; Lakatoš B; Breier A; Sulová Z
    Cells; 2020 Apr; 9(4):. PubMed ID: 32268491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of N-glycosylation in the structure and function of the methotrexate membrane transporter from CCRF-CEM human lymphoblastic leukemia cells.
    Matherly LH; Angeles SM
    Biochem Pharmacol; 1994 Mar; 47(6):1094-8. PubMed ID: 8147910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triorganotin Derivatives Induce Cell Death Effects on L1210 Leukemia Cells at Submicromolar Concentrations Independently of P-glycoprotein Expression.
    Bohacova V; Seres M; Pavlikova L; Kontar S; Cagala M; Bobal P; Otevrel J; Brtko J; Sulova Z; Breier A
    Molecules; 2018 May; 23(5):. PubMed ID: 29723984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of protein glycosylation reverses the MDR phenotype of cancer cell lines.
    Wojtowicz K; Januchowski R; Nowicki M; Zabel M
    Biomed Pharmacother; 2015 Aug; 74():49-56. PubMed ID: 26349962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of P-gp in leukemia cells is associated with cross-resistance to protein N-glycosylation inhibitor tunicamycin.
    Pavlikova L; Seres M; Imrichova D; Hano M; Rusnak A; Zamorova M; Katrlik J; Breier A; Sulova Z
    Gen Physiol Biophys; 2016 Oct; 35(4):497-510. PubMed ID: 27763330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thapsigargin on P-glycoprotein-negative and P-glycoprotein-positive L1210 mouse leukaemia cells.
    Sereš M; Ditte P; Breier A; Sulová Z
    Gen Physiol Biophys; 2010 Dec; 29(4):396-401. PubMed ID: 21157003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of N-linked glycosylation of P-glycoprotein by tunicamycin results in a reduced multidrug resistance phenotype.
    Kramer R; Weber TK; Arceci R; Ramchurren N; Kastrinakis WV; Steele G; Summerhayes IC
    Br J Cancer; 1995 Apr; 71(4):670-5. PubMed ID: 7710927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GalNAc-alpha-O-benzyl inhibits NeuAcalpha2-3 glycosylation and blocks the intracellular transport of apical glycoproteins and mucus in differentiated HT-29 cells.
    Huet G; Hennebicq-Reig S; de Bolos C; Ulloa F; Lesuffleur T; Barbat A; Carrière V; Kim I; Real FX; Delannoy P; Zweibaum A
    J Cell Biol; 1998 Jun; 141(6):1311-22. PubMed ID: 9628888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multidrug resistant P-glycoprotein positive L1210/VCR cells are also cross-resistant to cisplatin via a mechanism distinct from P-glycoprotein-mediated drug efflux activity.
    Gibalová L; Sedlák J; Labudová M; Barancík M; Reháková A; Breier A; Sulová Z
    Gen Physiol Biophys; 2009 Dec; 28(4):391-403. PubMed ID: 20097962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of glycomic alterations induced by overexpression of p-glycoprotein on the surfaces of L1210 cells using sialic acid binding lectins.
    Bubencíkova T; Cholujová D; Messingerová L; Mislovicova D; Seres M; Breier A; Sulova Z
    Int J Mol Sci; 2012 Nov; 13(11):15177-92. PubMed ID: 23203118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein.
    Bohácová V; Sulová Z; Dovinová I; Poláková E; Barancík M; Uhrík B; Orlický J; Breier A
    Toxicol In Vitro; 2006 Dec; 20(8):1560-8. PubMed ID: 16962737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insight into p-glycoprotein as a drug target.
    Breier A; Gibalova L; Seres M; Barancik M; Sulova Z
    Anticancer Agents Med Chem; 2013 Jan; 13(1):159-70. PubMed ID: 22931413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of benzyl-alpha-GalNAc, an inhibitor of mucin glycosylation, on cancer-associated antigens in human colon cancer cells.
    Huang J; Byrd JC; Yoon WH; Kim YS
    Oncol Res; 1992; 4(11-12):507-15. PubMed ID: 1284381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of the Mitochondrial Membrane Potential by the Cationic Dye JC-1 in L1210 Cells with Massive Overexpression of the Plasma Membrane ABCB1 Drug Transporter.
    Elefantova K; Lakatos B; Kubickova J; Sulova Z; Breier A
    Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of anticancer drugs: effects of pentoxifylline on neoplastic cells.
    Barancik M; Bohacova V; Gibalova L; Sedlak J; Sulova Z; Breier A
    Int J Mol Sci; 2012; 13(1):369-82. PubMed ID: 22312258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination.
    Ravindranath AK; Kaur S; Wernyj RP; Kumaran MN; Miletti-Gonzalez KE; Chan R; Lim E; Madura K; Rodriguez-Rodriguez L
    Oncotarget; 2015 Sep; 6(28):26308-21. PubMed ID: 26299618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation.
    Gibalová L; Sereš M; Rusnák A; Ditte P; Labudová M; Uhrík B; Pastorek J; Sedlák J; Breier A; Sulová Z
    Toxicol In Vitro; 2012 Apr; 26(3):435-44. PubMed ID: 22269388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation.
    Delannoy P; Kim I; Emery N; De Bolos C; Verbert A; Degand P; Huet G
    Glycoconj J; 1996 Oct; 13(5):717-26. PubMed ID: 8909998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.